The role of inflammation in DME

Article

The level of various inflammatory factors in the vitreous fluid is a significant factor in the severity of diabetic macular oedema (DME), according to study results published in the January issue of Ophthalmology.

The level of various inflammatory factors in the vitreous fluid is a significant factor in the severity of diabetic macular oedema (DME), according to study results published in the January issue of Ophthalmology.

Hideharu Funatsu, MD of the Tokyo Women's Medical University, Japan and colleagues conducted a retrospective case-control study of DME patients (n=53), patients with non-diabetic ocular disease (n=15) and diabetic patients who were free of retinopathy (n=8). The team examined samples of the vitreous fluid to determine levels of inflammatory factors, specifically vascular endothelial growth factor (VEGF), intercellular adhesion molecule (ICAM)-1, interleukin (IL)-6, monocyte chemotactic protein (MCP)-1, and pigment epithelium-derived factor (PEDF).

The researchers found that DME patients demonstrated significantly higher levels of VEGF, ICAM-1, IL-6 and MCP-1 when compared with other patient groups, although the level of PEDF was significantly lower in the vitreous of DME patients when compared with other patient groups. In addition, the levels of each of these inflammatory factors in the vitreous were associated with the thickness of the retina at the central fovea. VEGF and ICAM-1 had a greater influence on the severity of DME than IL-6, MCP-1 or PEDF.

The team concluded that the level of these inflammatory factors - particularly VEGF and ICAM-1 - in the vitreous correlate significantly to the permeability of the retina and the severity of DME.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.